These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28202171)

  • 1. Residual renal function: a paradigm shift.
    Lowenstein J; Grantham JJ
    Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rebirth of interest in renal tubular function.
    Lowenstein J; Grantham JJ
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1351-5. PubMed ID: 26936872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients.
    Cupisti A; Bolasco P; D'Alessandro C; Giannese D; Sabatino A; Fiaccadori E
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33921862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the efficacy of AST-120 (KREMEZIN
    Asai M; Kumakura S; Kikuchi M
    Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG; Hains DS; Bissler J; Pendley BD; Lindner E
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F890-F902. PubMed ID: 29537310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of organic anion transporters in the progression of chronic renal failure.
    Enomoto A; Niwa T
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Am J Kidney Dis; 2005 Sep; 46(3):512-9. PubMed ID: 16129214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
    Kiss I
    Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives.
    Magnani S; Atti M
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33808345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular Secretion in CKD.
    Suchy-Dicey AM; Laha T; Hoofnagle A; Newitt R; Sirich TL; Meyer TW; Thummel KE; Yanez ND; Himmelfarb J; Weiss NS; Kestenbaum BR
    J Am Soc Nephrol; 2016 Jul; 27(7):2148-55. PubMed ID: 26614381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.
    Snauwaert E; Van Biesen W; Raes A; Glorieux G; Van Bogaert V; Van Hoeck K; Coppens M; Roels S; Vande Walle J; Eloot S
    Nephrol Dial Transplant; 2018 Jun; 33(6):978-986. PubMed ID: 28992139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.
    Leong SC; Sao JN; Taussig A; Plummer NS; Meyer TW; Sirich TL
    J Am Soc Nephrol; 2018 Jul; 29(7):1992-1999. PubMed ID: 29728422
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
    Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.